![Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile](https://www.researchgate.net/profile/Idan-Goren-2/publication/369140627/figure/fig1/AS:11431281173653648@1688999891715/Nationwide-incidence-rate-of-each-strategy-in-Crohns-disease-patients-between-2005-to_Q320.jpg)
Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile
![PDF) Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+ Channel Gating PDF) Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+ Channel Gating](https://www.researchgate.net/profile/Jacopo-Difrancesco/publication/322797012/figure/fig5/AS:962714012774433@1606540315497/Effect-of-Dr-VSP-on-currents-from-Kv72-Kv73-heteromeric-channels-incorporating-mutant_Q320.jpg)
PDF) Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+ Channel Gating
![Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile](https://www.researchgate.net/profile/Idan-Goren-2/publication/369140627/figure/fig2/AS:11431281173653657@1688999894501/Predictors-of-failure-of-each-strategy-from-multivariable-Cox-regression-analysis_Q320.jpg)
Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile
![Erwin SANTO | Head of Department | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Institute of Gastroenterology | Research profile Erwin SANTO | Head of Department | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Institute of Gastroenterology | Research profile](https://www.researchgate.net/profile/Menachem-Moshkowitz/publication/277343810/figure/fig1/AS:1088585000333313@1636550297580/Expression-of-CD24-in-peripheral-blood-cell-lysates-from-adenoma-CRC-patients-and_Q320.jpg)
Erwin SANTO | Head of Department | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Institute of Gastroenterology | Research profile
![Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile](https://c5.rgstatic.net/m/437738464651637/images/template/default/profile/profile_default_l.jpg)
Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile
![Erwin SANTO | Head of Department | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Institute of Gastroenterology | Research profile Erwin SANTO | Head of Department | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Institute of Gastroenterology | Research profile](https://www.researchgate.net/profile/Federico-Salomone/publication/269172594/figure/fig1/AS:320754307616777@1453485194941/Flow-chart-of-the-study-participants-NAFLD-nonalcoholic-fatty-liver-disease-NASH_Q320.jpg)
Erwin SANTO | Head of Department | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Institute of Gastroenterology | Research profile
![Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile](https://www.researchgate.net/publication/364312853/figure/fig1/AS:11431281118903898@1675912332873/The-mean-number-of-Helicobacter-pylori-tests-in-the-5years-preceding-IBD-registry-entry_Q320.jpg)
Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile
![PDF) Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+ Channel Gating PDF) Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+ Channel Gating](https://i1.rgstatic.net/publication/322797012_Kv73_Compound_Heterozygous_Variants_in_Early_Onset_Encephalopathy_Reveal_Additive_Contribution_of_C-Terminal_Residues_to_PIP2-Dependent_K_Channel_Gating/links/5b3ab9e10f7e9b0df5e829b3/largepreview.png)
PDF) Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+ Channel Gating
![Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile Revital KARIV | Service for GI malignancies, head | Tel Aviv Sourasky Medical Center, Tel Aviv | TASMC | Gastroenterology Institute | Research profile](https://www.researchgate.net/publication/365683372/figure/tbl1/AS:11431281099162957@1669221328150/Individual-patients-outcome-of-polyp-number-burden-and-maximal-size-at-baseline-and_Q320.jpg)